| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6123307 | Journal of Infection | 2013 | 9 Pages |
Abstract
MRSA HVO was associated with more frequent persistent bacteremia (â¥7 days) and relapse, and longer hospital stay compared to MSSA HVO. Antibiotic therapy for â¥8 weeks and targeting a vancomycin trough of â¥15 mg/L may be benefit patients with MRSA HVO.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Ki-Ho Park, Yong Pil Chong, Sung-Han Kim, Sang-Oh Lee, Sang-Ho Choi, Mi Suk Lee, Jin-Yong Jeong, Jun Hee Woo, Yang Soo Kim,